Bone marrow-derived AC133+ and Mono-Nuclear Cells (MNC) implantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bone marrow-derived AC133+ and Mono-Nuclear Cells (MNC) implantation, covering 2012-12-27 to 2012-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient [Phase 2, Phase 3]